Finance

Lists
Why is TRAW up 4,50%?
Dive Deeper
TRAW:NASDAQ
Traws Pharma Inc
0,38 US$
+4,50%
(+0,016) 1D
20 ოქტ, 12:36:37 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TRAW...
Open
0,38 US$
High
0,39 US$
Low
0,37 US$
Mkt. cap
5,83 მლნ.
Avg. vol.
1,12 მლნ.
Volume
53,41 ათ.
52-wk high
3,23 US$
52-wk low
0,36 US$
EPS
-1,62 US$
Beta
1,52
Shares outstanding
15,37 მლნ.
No. of employees
6
Open
0,38 US$
High
0,39 US$
Low
0,37 US$
Mkt. cap
5,83 მლნ.
Avg. vol.
1,12 მლნ.
Volume
53,41 ათ.
52-wk high
3,23 US$
52-wk low
0,36 US$
EPS
-1,62 US$
Beta
1,52
Shares outstanding
15,37 მლნ.
No. of employees
6
News stories
From web sources and news partners
About Traws Pharma Inc
CEO-
Employees6
Founded1998
Headquarters-
SectorPharmaceutical industry
Websitetrawspharma.com
Analyst ratings
Based on 1 analyst giving stock ratings to TRAW in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for TRAW in the last 3 months
Highest
Current 0,38 US$
1,00 US$ (+161,10%)
Average
1,00 US$ (+161,10%)
Lowest
1,00 US$ (+161,10%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Hold
Reiterated
1,00 US$
+161,1%
08/18/2026
Kevin DeGeeter
Ladenburg Thalmann & Co.
Hold
Downgraded
-
-
06/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2,31 მლნ.
5,04 მლნ.
4,91 მლნ.
1,10 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,74 მლნ.
2,33 მლნ.
2,03 მლნ.
3,48 მლნ.
Operating expense
4,06 მლნ.
7,37 მლნ.
6,95 მლნ.
3,18 მლნ.
Total operating expenses
4,06 მლნ.
7,37 მლნ.
6,95 მლნ.
3,18 მლნ.
Operating income
-4,06 მლნ.
-7,37 მლნ.
-6,95 მლნ.
-3,18 მლნ.
Other non operating income
93,00 ათ.
-553,00 ათ.
-161,00 ათ.
121,00 ათ.
EBT including unusual items
-3,96 მლნ.
-7,44 მლნ.
-7,11 მლნ.
-3,05 მლნ.
EBT excluding unusual items
-3,96 მლნ.
-7,44 მლნ.
-7,11 მლნ.
-3,05 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-1,40 მლნ.
Net income
-3,96 მლნ.
-7,44 მლნ.
-7,11 მლნ.
-3,05 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-
-0,55
-0,52
-0,18
Interest and investment income
-
455,00 ათ.
-
-
Interest expense
-
-
-
-
Net interest expenses
-
455,00 ათ.
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-4,04 მლნ.
-7,32 მლნ.
-6,90 მლნ.
-3,13 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები